Keyphrases
Acinetobacter
16%
Acute Respiratory Distress Syndrome
17%
Adult Patients
14%
Antibiotic Resistance
20%
Antibiotics
20%
Antimicrobial
16%
Antimicrobial Resistance
36%
Bronchoalveolar Lavage
30%
Cefepime
18%
Ceftriaxone
18%
Community-acquired Pneumonia
14%
Confidence Interval
32%
Contact Tracing
20%
COVID-19
32%
Critical Care
23%
Critically Ill
20%
Critically Ill Patients
51%
Determinants of Outcome
13%
Empiric Antibiotics
17%
Epidemiology
17%
Gram-negative
20%
Gram-negative Bacilli
22%
Gram-negative Bacteria
23%
Healthcare Workers
15%
Hospitalized Patients
13%
Infection Recurrence
12%
Intensive Care Unit
55%
Lung
33%
Lung Transplantation
31%
Mechanical Ventilation
29%
Meropenem
14%
Methicillin-resistant Staphylococcus Aureus
25%
Multidrug-resistant Gram-negative Bacteria
13%
Multidrug-resistant Pathogens
14%
Odds Ratio
24%
Patients at Risk
20%
Pneumonia
24%
Retrospective Cohort Study
21%
Risk Factors
17%
Sepsis
46%
Sepsis Shock
44%
Septic Patients
16%
Septic Shock
80%
Severe COVID-19
12%
Severe Sepsis
30%
Skin Tissue
12%
Soft Tissue Infection
12%
US Hospitals
13%
Ventilation Rate
13%
Ventilator-associated Pneumonia
30%
Medicine and Dentistry
Acinetobacter
15%
Acute Respiratory Distress Syndrome
20%
Antibiotic Resistance
40%
Antibiotic Therapy
14%
Antibiotics
17%
Antiinfective Agent
23%
Antimicrobial Therapy
12%
Artificial Respiration
23%
Bloodstream Infection
14%
Breathing
11%
Broad-Spectrum Antibiotic
11%
Cefepime
12%
Clinician
14%
Cohort Effect
22%
Contact Examination
10%
COVID-19
40%
Cytokine
21%
Decision Making
10%
Diagnosis
28%
Gram-Negative Bacteria
33%
Gram-Positive Bacteria
12%
Hospital-Acquired Pneumonia
10%
Infection
89%
Intensive Care
10%
Intensive Care Unit
36%
Interleukin 6
12%
Interleukin 6 Receptor
10%
Lung
25%
Lung Biopsy
10%
Lung Lavage
27%
Lung Nodule
12%
Lung Transplantation
31%
Meropenem
11%
Methicillin Resistant Staphylococcus Aureus
15%
Multidrug Resistance
11%
Multilevel Analysis
10%
Odds Ratio
17%
Pathogen
64%
Rapid Response Team
10%
Receptor Blocking Agent
10%
Respiratory Failure
11%
Retrospective Cohort Study
16%
Reverse Transcription Polymerase Chain Reaction
10%
Sepsis
63%
Septic Shock
56%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
Soft Tissue Infection
11%
Steady State
10%
Transplantation
14%
Ventilator-Associated Pneumonia
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acinetobacter
15%
Adult Respiratory Distress Syndrome
20%
Aminoglycoside
10%
Antibiotic Therapy
11%
Antibiotics
31%
Antiinfective Agent
12%
Antimicrobial Resistance
43%
Antimicrobial Therapy
12%
Aspergillus
10%
Bloodstream Infection
18%
Candidemia
10%
Cardiogenic Shock
10%
Cefepime
17%
Ceftriaxone
17%
Cohort Study
28%
Coronavirinae
10%
Crackle
10%
Cytokine
22%
Diseases
29%
Gram Negative Bacterium
44%
Gram Positive Bacterium
12%
Hospital Acquired Pneumonia
10%
Hospital Mortality
20%
Host Factor
10%
Hypotension
10%
Infection
100%
Infectious Agent
66%
Interleukin 6
12%
Interleukin 6 Receptor
10%
Lung Nodule
10%
Macaca fascicularis
10%
Meropenem
14%
Methicillin Resistant Staphylococcus Aureus Infection
12%
Methicillin-Resistant Staphylococcus Aureus
23%
Microorganism
10%
Mortality Rate
10%
Mould
10%
Multidrug Resistance
11%
Number Needed to Treat
10%
Piperacillin Plus Tazobactam
10%
Pseudomonas aeruginosa
12%
Receptor Blocking Agent
10%
Recurrent Disease
12%
Respiratory Failure
11%
SARS Coronavirus
18%
Seasonal Influenza
10%
Secondary Infection
10%
Sepsis
63%
Septic Shock
64%
Soft Tissue Infection
11%